Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. - Wikidata - awgldk - TriplyDB

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

http://www.wikidata.org/entity/Q39366376

about

Current understanding of coronary artery calcification Klotho in cardiovascular disease: Current and future perspectives Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease Klotho, stem cells, and aging Mechanisms of arterial calcifications and consequences for cardiovascular function Regulatory circuits controlling vascular cell calcification Fibroblast growth factor 23 Vascular calcification--is aldosterone a culprit?Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Fibroblast growth factor signaling in the vasculature Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.Vascular calcification: When should we interfere in chronic kidney disease patients and how?NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Fibroblast Growth Factor-23-A Potential Uremic Toxin MICS, an easily ignored contributor to arterial calcification in CKD patients.Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients.Lack of FGF23 response to acute changes in serum calcium and PTH in humans.α-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice.Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4 CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.FGF23 protein expression in coronary arteries is associated with impaired kidney function.αKlotho and vascular calcification: an evolving paradigm.FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease.Chronic kidney disease: mineral and bone disorder in children.Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.Arterial klotho expression and FGF23 effects on vascular calcification and function.

P2860

Q26770851-AAA134C5-4118-47D9-9302-2A9A43CC930E Q26775409-98B66897-7985-4C32-A6BA-D536B1A23F9F Q26782946-D12F137E-4A29-459F-A0E5-6200C71CF9A2 Q26783185-81C2D362-D068-4397-B577-B181A01C75D1 Q26821993-6A7804D0-B8F9-41AD-ABDE-B1B1E4FD3A22 Q26825788-C99EA36E-C47D-4248-8B5A-3BE756587406 Q26829294-04FA81F2-B3CB-432A-A884-6ADC11D4F10E Q26851687-5F20DF87-F03B-498A-85C3-5B4938EA507C Q26863412-BAA96219-7401-40A1-9130-5D7D84770F61 Q26866263-C80DC4BC-EFA8-4AEB-8AF3-7A2CF06E4981 Q27002431-4F802E93-B2AD-4CFA-AD6C-12C9E98372EC Q27011668-ED1ACBF9-A074-4229-A3C0-32F5D6DC30D5 Q27024043-686386A9-1174-4339-9C68-0B1808CE5F94 Q27342649-D094B737-EA79-4314-BF32-F66747D3B2F8 Q28071582-3504AF08-4166-4058-A06B-DE43B0DE4AAD Q28072348-861BBEEF-829C-4E04-8EAA-0C34E2BEEFE0 Q28075648-B4777024-5D69-4127-BC66-1F7FBFCB63B4 Q30249410-6C650271-E6AB-42D8-8EA5-2F9B00F0D354 Q30544587-CC3037E9-B264-4F4D-A71D-8D45BC813089 Q30852321-892C033D-BF2E-4377-BC27-0FBF0BB835C9 Q31171853-D63267BD-8C2A-42E2-BE35-8020949FE2CC Q33570120-DF0AB3A9-9B85-4540-B853-F7A69DFBAF85 Q33626706-B8877ABE-A2A4-4616-B6F7-00CD4754C9E6 Q33627219-509FE8C6-BCC6-496A-AD6D-5FC38FE4FFE6 Q33654616-155AF67F-A5B6-4BBF-AF36-C9A209CAB61B Q33703957-5D30B6C5-DF1E-47F8-8A42-7A52D3C1094C Q33715785-15AD66B2-AAAA-41BD-84D2-B835A0A45421 Q33974636-115F2ABD-55F0-4FC8-A376-BD408A66092B Q33985430-EB53EDA9-05E5-4C4E-91BE-1ED562A4ACC1 Q34078872-88611BE7-82EF-4CBA-AF1F-1ED65FA9A9EA Q34130840-7B0B806A-7115-42E5-8A7D-49928CD943FD Q34337575-5352B829-5146-49B1-9D21-BF780F4E8E06 Q34402661-D938FC92-9E3C-4BBF-A418-F76F907B9F47 Q34406871-51A135D4-6515-4D64-AAED-9A08EB56A057 Q34421217-4C7A7929-D388-4140-A569-E3B77DD37296 Q34487209-E88AB4E2-CE19-4EAC-8D28-D7923A2639BA Q34557041-C6056FDD-0188-488B-9674-98B32091F0BD Q34595154-34E3DD3C-F5FD-471D-A47C-151D5D9FE783 Q34614907-7DE62B53-6781-4406-970E-FE96F6BB3337 Q34663898-4F6D0D07-5EBC-458B-92DD-1FDE3BFC0497

P2860

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

http://www.wikidata.org/entity/Q39366376

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@en

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@nl

type

label

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@en

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@nl

prefLabel

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@en

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@nl

P1433

Q39366376-BBA368B5-D77F-4EBA-88E5-C7BCF66C47D8

P1476

Q39366376-F04FBF27-D35E-44C3-9996-A2B46AD5D37C

P2093

Q39366376-52498D91-EBD7-4BAB-BE30-C4DDF6A5EF36

Q39366376-57BBD3E8-82D8-4BB5-B247-11195050250C

Q39366376-CE484321-7EF1-4A9A-BD7F-90BE83E21D64

Q39366376-D623B930-113A-45DC-9420-89CCC6EBD602

Q39366376-E24E5031-E816-4F13-BC1B-FCEAE9494BAC

Q39366376-E7DFB242-B01E-4EA7-BA1B-0A72AB4FF93C

Q39366376-EF45ACAB-41F1-4FFB-8408-688EC12D1803

P304

Q39366376-9C467152-1D37-40F8-AC6A-6FBE220A1A5D

P31

Q39366376-58A71437-0268-4B02-A472-BCE47EC5EACB

P356

Q39366376-DEFCF935-E1B7-49D7-8396-B56CA6A45B83

P407

Q39366376-20676735-97EC-4CBC-AF36-3F8872D6A9D7

P433

Q39366376-A3860416-D444-46BA-AB3B-7CCB4249435E

P478

Q39366376-9B6EF3B1-8F07-4700-BED0-6956428A52DC

P577

Q39366376-C488F815-4922-47BC-B4FA-B06055F60D76

P698

Q39366376-663616AD-1E5D-4803-9432-A0AC155785B2

P356

CIRCULATIONAHA.111.053405

P1433

P1476

Vascular Klotho deficiency pot ...... o fibroblast growth factor 23.

@en

P2093

Christina Lee

http://www.w3.org/2001/XMLSchema#string

Daniel Zehnder

http://www.w3.org/2001/XMLSchema#string

F T Lam

http://www.w3.org/2001/XMLSchema#string

Guerman Molostvov

http://www.w3.org/2001/XMLSchema#string

Kenneth Lim

http://www.w3.org/2001/XMLSchema#string

Li-Li Hsiao

http://www.w3.org/2001/XMLSchema#string

Tzong-Shi Lu

http://www.w3.org/2001/XMLSchema#string

P304

2243-2255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.111.053405

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22492635

http://www.w3.org/2001/XMLSchema#string